Grace Therapeutics

Grace Therapeutics 的所有者是 Neptune Wellness Solutions.

Neptune Wellness Solutions 是一家在股票代码 NEPT (CA) 下上市的公司。

他们在：

• 分配50%
• 药店50%

涉及Neptune Wellness Solutions的并购和融资。

• Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).

查看带有其 8 名主要高管的组织结构图

Grace Therapeutics 搜索最多的简介

• Prashant Kohli, Chief Executive Officer and Director
• Vimal Kavuru, Director
• Donald Olds, Director

高管在Neptune Wellness Solutions变化

• Cedrick Billequey 曾任 General Manager of Biodroga Nutraceuticals, Inc, 现任 Interim Chief Operating Officer and General Manager of Biodroga Nutraceuticals, Inc  (新闻发布的2024八月9号).

创建提醒
跟踪 Grace Therapeutics 的高管变动

Neptune Wellness Solutions 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。

Popular M&A news in 药店

• Stemtech and Seacret Direct have announced they will merge  (公布2024十二月5号)..
• Recursion Pharma and Exscientia have merged  (公布2024十一月27号)..
• Stemtech and Seacret Direct have announced they will merge  (公布2024十一月22号)..

药店 行业的其他推荐联系人

• Adare Pharmaceuticals 企业 Kristin Berkinsky - Chief Human Resources Officer
• Sanofi 企业 Julie Van Ongevalle - Executive Vice President and Head of Consumer Healthcare
• Amneal Pharmaceuticals 企业 Paul Meister - Chairman of the Board

了解更多有关药店行业的信息 >

Grace Therapeutics 的最新新闻稿

• Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
• Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update
• Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024
• Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
• Acasti to Present at the Life Sciences Investor Forum
• Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
• Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
• Acasti Announces Year-End 2024 Financial Results, Provides Business Update
• Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
• Acasti Pharma to Attend BIO International Convention 2024
• View more press releases Close

关于 Grace Therapeutics 的社交媒体

• Grace Therapeutics 在 维基百科、谷歌新闻 和 雅虎财经
• Grace Therapeutics 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Prashant Kohli

致电Grace Therapeutics，电话：+1 450...

查看组织结构图

Register to receive your alert

报告错误